Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Disease × Drug Therapy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 21 Breast Neoplasms 9 Stomach Neoplasms 7 Lung Neoplasms 7 Small Cell Lung Carcinoma 5 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Colorectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Esophageal Squamous Cell Carcinoma 4 Neoplasms 3 NSCLC 3 Esophageal Neoplasms 3 Urinary Bladder Neoplasms 2 Recurrence 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Muscle-invasive Bladder Cancer 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Limited Stage Small Cell Lung Cancer 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Upper Tract Urothelial Carcinoma 1 Thymus Neoplasms 1 Resectable Non-small Cell Lung Cancer 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Pancreatic Ductal Adenocarcinoma 1

Interventions

Tomography, X-Ray Computed 2 Colonoscopy 2 gilteritinib 1 Surveys and Questionnaires 1 Standard of Care 1 Sequence Analysis, RNA 1 Preoperative Exercise 1 Nutritional Status 1 Nutrition Assessment 1 Methods 1 Liquid Biopsy 1 Hysterectomy 1 Exercise 1 Endoscopy 1 Educational Status 1 Drug Therapy 1 Diagnostic Tests, Routine 1 DNA 1 Capecitabine 1 Bupivacaine 1 Bevacizumab 1 Acupressure 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07134101 2025-08-29

SMARTi-RC01

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Not yet recruiting

Gastrointestinal

Disease, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡